| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | Muon Space | Industrial Aerospace & Defense | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | $2M | -- | 1 | Not available | -- | -- | $386.23M | Series C | 8/20/2026 | $250M | $1.5B | $11.79 | Eclipse Capital, Galvanize, Google, Salesforce Ventures, Wellington Management, I Squared Capital, Woven Capital, Radical Ventures, Congruent Ventures, Costanoa Ventures, Activate Capital, ACME Capital, ArcTern Ventures, Overlap Holdings | ||||
 | Vedanta Biosciences | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $126.86M | Series B-1 | 8/6/2026 | $22.57M | $113.87M | $0.17 | AMR Action Fund, BNP Paribas | ||||
 | Baylor Genetics | Healthcare Other Healthcare | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $152M | Series B | 7/1/2026 | $50M | $443.35M | $19.25 | Undisclosed Investors | ||||
 | Caplight | Fintech Capital Markets | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $25.92M | Series A | 6/24/2026 | $14.57M | $80.59M | $3.93 | BlackRock, Fin Capital, UBS, LEAP Global Partners, Deutsche Borse, Better Tomorrow Ventures, Clocktower Ventures, Dash Fund | ||||
 | Circle Pharma | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $303.25M | Series E-1 | 9/16/2026 | $62.01M | $245.27M | $0.27 | The Column Group, Nextech Invest, RA Capital Management, Euclidean, Eli Lilly and Company | ||||
 | Function Health | Healthcare Digital Health | Low | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $521.18M | Series B-2 | 7/30/2026 | $94.11M | $2.94B | $92.23 | Undisclosed Investors | ||||
 | Order.co | Fintech Fintech Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $145.99M | Series D | 6/23/2026 | $90M | $316.12M | $1.38 | Undisclosed Investors | ||||
 | Positron | Industrial Other Industrial | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $100.02K | -- | 1 | -- | Not available | -- | -- | $1.19B | Series C-1 | 9/10/2026 | $500M | $5B | $83.44 | NEA, Jim Clark, DFJ Growth, Qatar Investment Authority, Resilience Reserve, ARENA Private Wealth, Natural Capital, Helena, 1517 Fund, Flume Ventures, Unless, Boardman Bay Capital Management, Fincadia Advisors, Banyan Ventures, U First Capital, VentureTech Alliance, Hudson River Trading, Cisco Investments, NAVER Ventures | ||||
 | Qualified Health | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $165.06M | Series A-2 | 7/15/2026 | $10M | $769.76M | $37.62 | Undisclosed Investors | ||||
 | Warp Co | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $83.27M | Series B | 6/25/2026 | $60M | $303.19M | $8.97 | Battery Ventures, Peak XV, Sound Ventures, Y Combinator, Tobi Lutke, Hughes Johnson, Drew Houston, Arash Ferdowsi, Balaji Srinivasan, Kevin Hartz, Kyle Vogt, Amjad Masad, HOF Capital, Sapphire Ventures | ||||
 | Cadence Solutions | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $243.46M | Series C | 6/23/2026 | $100M | $1.2B | $4.60 | Spark Capital, Thrive Capital, General Catalyst, Coatue, B Capital, Corewell Health Ventures, Memorial Hermann, Duke Health | ||||
 | Encoded Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $945.89M | Series F | 9/9/2026 | $275M | $629.69M | $3.40 | GV, ARCH Venture Partners, Braidwell, Farallon Capital Management, Illumina Ventures, Invus, Janus Henderson Investors, Matrix Capital Management, Nolan Capital, RTW Investments, SoftBank, Venrock | ||||
 | Galileo Health | Healthcare Healthcare Providers & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $265.94M | Series F | 8/14/2026 | $30.13M | $387.07M | $3.68 | Undisclosed Investors | ||||
 | Premier Lacrosse League | Consumer & Lifestyle Media | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $231.56M | Series E | 6/30/2026 | $100M | $548.43M | $10.90 | Ares Management, Joe Tsai Sports, ESPN, Glen Powell, Rob Mac, Warren Zeiders, Tony Cavalero, Creator Sports Capital, Next 3, FirstTracks Sports Ventures, Jed Hart, West End Investment Management, James Young, Bolt Ventures, Chris Shumway | ||||
 | Qualia | Real Estate Real Estate Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $200.00K | -- | 1 | -- | Not available | -- | -- | $249.6M | Series E | 8/27/2026 | $50M | $1.48B | $10.85 | Undisclosed Investors | ||||
 | Torus | Energy Clean Energy | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $674.11M | Series C-1 | 6/25/2026 | $290M | $4.05B | $21.82 | Undisclosed Investors | ||||
 | Concentric AI | Enterprise Software Data Management / Storage | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $136.15M | Series C | 7/10/2026 | $62M | $383.5M | $3.98 | Undisclosed Investors | ||||
 | Emergent | Enterprise Software Software Development | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $230.5M | Series C | 7/15/2026 | $130M | $1.5B | $36.28 | Creaegis, MNI Ventures, Claypond Capital, Sentinel Global, Khosla Ventures, SoftBank, Lightspeed Venture Partners, Y Combinator | ||||
 | Gimlet Labs | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $165.00K | -- | 1 | -- | Not available | -- | -- | $352.35M | Series B-3 | 9/4/2026 | $41.91M | $3B | $50.28 | Andreessen Horowitz, Sapphire Ventures, Menlo Ventures, 645 Ventures, Arm Holdings, Eclipse Capital, Emergence, Factory, Hudson River Trading, M12, OnePrime Capital, Prosperity7, QuantumLight, Samsung Ventures, Tiger Global Management, Triatomic Capital, Wing Ventures, XTX Markets | ||||
 | Lightfield | Enterprise Software Communication & Collaboration Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $72.09M | Series A Prime | 9/9/2026 | $47.09M | $121.17M | $1.39 | Andreessen Horowitz, Maverick Capital, Coatue, Audacious Ventures, Alumni Ventures, Greylock Partners, Lightspeed Venture Partners, Mistral Venture Partners | ||||
 | Medallion | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $136.62M | Series C-1 | 9/2/2026 | $12M | $515.55M | $0.70 | Undisclosed Investors | ||||
 | Abcuro | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $353.25M | Series D-1 | 8/18/2026 | $32.35M | $120.99M | $0.60 | New Leaf Venture Partners, Rock Springs Capital, Abrdn, Bain Capital Life Sciences, Samsara BioCapital, Redmile Group, Mass General Brigham Ventures, RA Capital Management, Pontifax, Sanofi Ventures, Foresite Capital, New Enterprise Associates, Eurofarma Ventures, Kaitai Capital, Soleus Capital, Nancy Chang, ShangBay Capital | ||||
 | AfterQuery | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $83.55M | Series B | 8/18/2026 | $50.27M | $3.2B | $194.02 | Undisclosed Investors | ||||
 | AKASA | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $323.65M | Series D-1 | 7/8/2026 | $55.25M | $968.13M | $32.61 | Undisclosed Investors | ||||